Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Cowan

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Drug resistance markers: are they bad or good?C Morrow, K H Cowan
The Medical Journal of Australia|March 21, 1994
Multiple drug resistance in cancer therapyE Schneider, K H Cowan
The Journal of Biological Chemistry|September 10, 1984
A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamatesK H Cowan, J Jolivet
Journal of the National Cancer Institute|April 18, 1990
Multidrug resistance associated with altered topoisomerase II activity--topoisomerases II as targets for rational drug designC S Morrow, K H Cowan
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|January 1, 1990
Glutathione S-transferases and drug resistanceC S Morrow, K H Cowan
Journal of the National Cancer Institute|March 2, 1988
Multidrug resistanceJ A Moscow, K H Cowan
Molecular Pharmacology|April 1, 1988
Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequencesM E Goldsmith, K H Cowan
Oncology (Williston Park, N.Y.)|October 1, 1988
Mechanisms and clinical significance of multidrug resistanceC S Morrow, K H Cowan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Multidrug resistanceJ A Moscow, K H Cowan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Multidrug resistanceJ A Moscow, K H Cowan
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Drug resistance markers: are they bad or good?C Morrow, K H Cowan
The Medical Journal of Australia|March 21, 1994
Multiple drug resistance in cancer therapyE Schneider, K H Cowan
The Journal of Biological Chemistry|September 10, 1984
A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamatesK H Cowan, J Jolivet
Journal of the National Cancer Institute|April 18, 1990
Multidrug resistance associated with altered topoisomerase II activity--topoisomerases II as targets for rational drug designC S Morrow, K H Cowan
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|January 1, 1990
Glutathione S-transferases and drug resistanceC S Morrow, K H Cowan
Journal of the National Cancer Institute|March 2, 1988
Multidrug resistanceJ A Moscow, K H Cowan
Molecular Pharmacology|April 1, 1988
Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequencesM E Goldsmith, K H Cowan
Oncology (Williston Park, N.Y.)|October 1, 1988
Mechanisms and clinical significance of multidrug resistanceC S Morrow, K H Cowan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Multidrug resistanceJ A Moscow, K H Cowan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Multidrug resistanceJ A Moscow, K H Cowan
Pageof 16